Investing Profile

Daniela Begolo

InvestorVC
Managing Director at EQT Life Sciences
eqtgroup.com/about/people/dan...Amsterdam, Netherlands
Photo of Daniela Begolo, Managing Director at EQT Life Sciences

Signal uses Gmail to reveal intro paths. Email content is never read.

Sign in with Google →
cb
EQT Life Sciences Managing Director
$11.0M - $65.0M
$25.0M
3
€260M
CompanyStageDateRound SizeTotal Raised
Kinaset Therapeutics
Series BJan 2026$100M
$140M
Co-investors: Jamil Beg (5am Ventures)
Splice Bio
Series BJun 2025$140M
$190M
Co-investors: Joël Jean-Mairet (Ysios Capital), Carole Nuechterlein (Roche Venture Fund), Beat Steffen (Novartis Venture Fund), Laia Crespo (Sanofi Ventures), Sylvain Sachot (Asabys Partners)
Mosanna Therapeutics
Series AJun 2025$80M
$80M
Principal Inkef2022 - 2022